AEZS Aeterna Zentaris Inc

MicroStockProfit.com announces a stock report featuring Aeterna Zentaris Inc. (Nasdaq:AEZS). The report briefly notes the company's most recent developments and news, and outlines its financial position, market performance, and comparison against industry peers.

The full report is available at: www.microstockprofit.com/lp/AEZS

Aeterna Zentaris Inc. (AEZS) is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. AEZS's deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options.

This newsletter has been helping traders make great investment decisions on AEZS; click here for a 25% discount offer.

In the report, the analyst notes:

"Shares of the Quebec-based cancer and endocrine drug maker jumped as much as 14% on Tuesday after it announced positive results of its completed phase III study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency (AGHD)."

"The Company added that it is currently proceeding with further detailed analyses of the data and preparing for a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) in the upcoming months, which would be followed by the filing of an NDA for the registration of AEZS-130 in the United States."

To read the entire report visit: www.microstockprofit.com/lp/AEZS

See what investors are saying about AEZS at http://www.stockhideout.com

Get breaking news on AEZS at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

CONTACT: Jay Geller
         info@microstockprofit.com
         1-888-307-2850